Patient Control Epidural Versus Conventional Epidural.
Launched by LIAQUAT NATIONAL HOSPITAL & MEDICAL COLLEGE · Dec 3, 2024
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
More than 20 years of successful usage of epidural analgesia for post operative pain treatment include intermittent provider-administer bolus, patient control analgesia and continuous epidural infusion with or without patient control epidural analgesia. The main drawback of conventional epidural infusion is that it does not allow for individual variation in management of pain. As a result, patient control epidural analgesia has replaced it in recent years.3. It has been demonstrated that continuous epidural infusion with patient control epidural analgesia is highly effective at providing co...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years. ASA 1-2 on pre anesthesia evaluation. Spontaneous breathing. Spo2 \>95% Informed consent for participation.
- Exclusion Criteria:
- • A history of long-term opioid therapy (use of opioid analgesic at doses higher than codeine 120mg/day, hydrocodone 40mg/day, tramadol 200mg/day or oxycodone 40mg/day 0-4 days before surgery).
- • Indication of revision surgery during immediate post operative care. Acute skin disease. Patients' refusal. ASA 3 and 4. Hypersensitivity to study drugs.
About Liaquat National Hospital & Medical College
Liaquat National Hospital & Medical College (LNH&MC) is a leading healthcare institution in Pakistan renowned for its commitment to advancing medical research and patient care. Established with the mission to provide high-quality healthcare services, LNH&MC integrates clinical practice with medical education and research, fostering an environment conducive to innovation. The institution is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals dedicated to conducting rigorous clinical trials aimed at enhancing treatment outcomes and improving health standards. As a sponsor of clinical trials, LNH&MC prioritizes ethical standards, patient safety, and scientific integrity, contributing significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported